QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Virios Therapeutics (VIRI) News Today

$0.37
-0.01 (-2.62%)
(As of 02/29/2024 ET)
SourceHeadline
investing.com logoVirios Therapeutics announces salary cuts for employees and board
investing.com - February 29 at 5:35 PM
markets.businessinsider.com logoVirios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
markets.businessinsider.com - February 29 at 12:35 PM
globenewswire.com logoVirios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - February 29 at 9:15 AM
markets.businessinsider.com logoVirios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
markets.businessinsider.com - February 28 at 11:24 AM
globenewswire.com logoVirios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
globenewswire.com - February 28 at 9:15 AM
investing.com logoVirios Therapeutics Llc (VIRI)
investing.com - February 27 at 7:37 AM
msn.com logoVirios Therapeutics (VIRI) Price Target Increased by 14.29% to 4.08
msn.com - February 25 at 12:10 AM
morningstar.com logoVirios Therapeutics Inc Ordinary Shares VIRI
morningstar.com - February 9 at 12:13 AM
finance.yahoo.com logoVIRI: Moving IMC-2 into Phase 2 Program in Long COVID
finance.yahoo.com - February 7 at 1:09 PM
finance.yahoo.com logoFibromyalgia Treatment Market revenue to cross USD 536 Million by 2033, says Research Nester
finance.yahoo.com - February 6 at 3:37 PM
benzinga.com logoVirios Therapeutics Stock (NASDAQ:VIRI) Dividends: History, Yield and Dates
benzinga.com - January 23 at 10:37 PM
finanznachrichten.de logoVirios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
finanznachrichten.de - January 22 at 3:19 PM
finance.yahoo.com logoVirios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
finance.yahoo.com - January 22 at 10:18 AM
markets.businessinsider.com logoVirios Therapeutics Reports Receipt Of FDA's Feedback On Requirements For Advancing IMC-2
markets.businessinsider.com - January 2 at 9:21 AM
finance.yahoo.com logoVirios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
finance.yahoo.com - January 2 at 9:21 AM
morningstar.com logoVirios Therapeutics Inc Ordinary Shares
morningstar.com - December 7 at 10:47 PM
finance.yahoo.com logoVirios Therapeutics, Inc. (NASDAQ:VIRI) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 14 at 1:38 PM
finance.yahoo.com logoVIRI: Provides Overview of Phase 3 Program in Fibromyalgia
finance.yahoo.com - November 13 at 3:00 PM
msn.com logoVirios Therapeutics GAAP EPS of -$0.06 beats by $0.04
msn.com - November 13 at 10:00 AM
finance.yahoo.com logoVirios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 13 at 10:00 AM
finance.yahoo.com logoVirios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 13 at 10:00 AM
msn.com logoSenti stock soars 175% on Chinese development deal for cancer drug
msn.com - November 6 at 6:12 PM
finance.yahoo.com logoVirios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
finance.yahoo.com - November 6 at 8:11 AM
finance.yahoo.com logoVirios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023
finance.yahoo.com - October 12 at 8:02 AM
finance.yahoo.com logoVirios Therapeutics Announces Termination of At-The-Market Sales Agreement
finance.yahoo.com - September 18 at 10:11 AM
finance.yahoo.com logoVirios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023
finance.yahoo.com - September 12 at 10:26 AM
finance.yahoo.com logoVIRI: Phase 3 Program in Fibromyalgia to Initiate in mid-2024…
finance.yahoo.com - August 15 at 1:58 PM
benzinga.com logoWhat In The World Is Going On With Virios Therapeutics (VIRI) Stock?
benzinga.com - August 14 at 3:20 PM
marketwatch.com logoVirios Therapeutics Shares Rise 11% After Halt to At-The-Market Offering Sales
marketwatch.com - August 14 at 3:20 PM
finance.yahoo.com logoVirios Therapeutics Announces Halt to At-The-Market Offering Sales
finance.yahoo.com - August 14 at 10:04 AM
finance.yahoo.com logoVirios Therapeutics, Inc. (NASDAQ:VIRI) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 12 at 10:42 AM
finance.yahoo.com logoVirios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 10 at 10:22 AM
benzinga.com logoVirios Therapeutics's Earnings Outlook
benzinga.com - August 9 at 1:34 PM
finance.yahoo.com logoVirios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia
finance.yahoo.com - August 9 at 8:33 AM
finance.yahoo.com logoVirios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
finance.yahoo.com - August 3 at 4:48 PM
msn.com logoVirios Therapeutics (VIRI) Price Target Increased by 75.00% to 3.57
msn.com - August 2 at 7:59 AM
finance.yahoo.com logoVIRI: Encouraging Results for IMC-2 in Long COVID…
finance.yahoo.com - July 24 at 2:26 PM
finance.yahoo.com logoVirios Therapeutics Long COVID Combo Therapy Shows Improvements: Long-COVID Impacts 65M People
finance.yahoo.com - July 17 at 3:47 PM
finance.yahoo.com logoVirios Therapeutics Announces Positive Data Demonstrating Improvement in Multiple Long-COVID Symptoms Following Treatment with a Combination of Valacyclovir and Celecoxib in an Exploratory, Open-Label, Proof of Concept Study
finance.yahoo.com - July 17 at 10:27 AM
seekingalpha.com logoCCL, S and LL are among pre market gainers
seekingalpha.com - June 12 at 4:08 PM
finance.yahoo.com logoVirios Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
finance.yahoo.com - May 25 at 6:06 PM
finance.yahoo.com logoVIRI: Ready to Move IMC-1 Into Phase 3 Program…
finance.yahoo.com - May 16 at 5:18 PM
finance.yahoo.com logoVirios Therapeutics Announces Submission of Final Toxicology Results to Support Proposed Phase 3 Program for Novel Therapy to Treat Fibromyalgia
finance.yahoo.com - May 15 at 8:38 AM
marketwatch.com logo10-Q: VIRIOS THERAPEUTICS, INC.
marketwatch.com - May 12 at 7:09 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Hold Rating on Virios Therapeutics (VIRI)
markets.businessinsider.com - May 12 at 9:08 AM
benzinga.com logoRecap: Virios Therapeutics Q1 Earnings
benzinga.com - May 11 at 8:05 AM
finance.yahoo.com logoVirios Therapeutics Announces First Quarter 2023 Financial Results
finance.yahoo.com - May 11 at 8:05 AM
msn.com logoEarnings Preview: Virios Therapeutics
msn.com - May 10 at 5:01 PM
finance.yahoo.com logoVirios Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
finance.yahoo.com - May 4 at 8:18 AM
proactiveinvestors.com logoVirios Therapeutics stock doubles as fibromyalgia program moves forward
proactiveinvestors.com - April 25 at 3:10 PM
Get Virios Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIRI and its competitors with MarketBeat's FREE daily newsletter.



VIRI Media Mentions By Week

VIRI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VIRI
News Sentiment

0.38

0.60

Average
Medical
News Sentiment

VIRI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VIRI Articles
This Week

9

1

VIRI Articles
Average Week

Get Virios Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIRI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VIRI) was last updated on 2/29/2024 by MarketBeat.com Staff